<div class="partial-page">

    <view-title>About</view-title>

    <div class="ot-content-header">
        <div class="container">
            <h3 id="frequently-asked-questions">About the Open Targets Platform</h3>
            <p></p>
        </div>
    </div>

    <div class="container">

        <div class="row">

            <div class="col-sm-4 pull-right">
                <div>
                    <ul class="plain arrow-icon">
                        <li><a href="#getting_started">Getting started with a text search</a></li>
                        <li><a href="#evidence">The data sources for target-disease associations</a></li>
                        <li><a href="#scoring">The score of target-disease associations</a></li>
                        <li><a href="#api">Accessing the Open Targets data with an API</a></li>
                        <li><a href="#citation">How to cite us</a></li>
                        <li><a href="#connect">Connect with us</a></li>
                    </ul>
                </div>
            </div>

            <div class="col-sm-8">

                <div class="ot-docs-section">
                    <p>The Open Targets Platform is a comprehensive and robust data integration for access to and visualisation of potential drug targets associated with disease. It brings together multiple data types and aims to assist users to identify and prioritise targets for further investigation.</p>

                    <p>A drug target can be a protein, protein complex or RNA molecule and it’s displayed by its gene name from the Human Gene Nomenclature Committee, <a href="http://www.genenames.org/">HGNC</a>. We integrate all the evidence to the target using <a href="http://www.ensembl.org/info/genome/stable_ids/index.html">Ensembl stable IDs</a> and describe relationships between diseases by mapping them to <a href="http://www.ebi.ac.uk/efo/">Experimental Factor Ontology</a> (EFO) terms.</p>

                    <p>The Platform supports workflows starting from a target or disease, and shows the available evidence for target – disease associations. Target and Disease profile pages showing specific information for both target (e.g baseline expression) and disease (e.g. Disease Classification) are also available.</p>
                </div>


                <div class="ot-docs-section">
                    <h4><a name="getting_started"></a>Getting started with a text search</h4>

                    <p>The search box is available on the <a href="https://www.targetvalidation.org/">Open Targets Platform</a> homepage and at the top of every other page.</p>

                    <p>You can search for a disease name, a gene name (or official symbol) or a protein name (or symbol). You can also search for synonyms and abbreviations for both genes (e.g. p53) and diseases (AD for Alzheimers disease), provided these alternative names are listed in the original sources from which we get this data from, e.g. HGNC (for genes) and Experimental Factor Ontology (for diseases and phenotypes).</p>

                    <p>Head to our <a href="https://docs.targetvalidation.org">documentation</a> for more details.</p>
                </div>



                <div class="ot-docs-section">

                    <h4><a name="evidence"></a>The data sources for target-disease associations</h4>

                    <p>We provide details of the evidence (e.g. UniProt) used for all the associations we have identified. Check our <a href="https://docs.targetvalidation.org/data-sources/">Data Sources</a> to find out which evidence we have used in our computational analyses.</p>

                </div>



                <div class="ot-docs-section">

                    <h4><a name="scoring"></a>The score of target-disease associations</h4>

                    <p>We allow for the prioritisation of targets by <a href="https://docs.targetvalidation.org/scoring.html">scoring target-disease associations</a> based on our data sources. Our scoring system varies from 0 to 1, the latter represents the strongest association, and it’s calculated based on the confidence levels in the evidence.</p>

                </div>



                <div class="ot-docs-section">

                    <h4><a name="api"></a>Accessing the Open Targets Platform with an API</h4>

                    <p>You can access all this data programmatically via our REST API services. We list the methods available, the supported formats and the endpoints in our <a href="https://api.opentargets.io/v3/platform/docs/swagger-ui">API documentation</a>.</p>

                </div>


                <div class="ot-docs-section">

                    <h4><a name="citation"></a>How to cite us</h4>

                    <p>If you use the Open Targets Platform in your work, please cite our latest paper <a href="https://academic.oup.com/nar/advance-article/doi/10.1093/nar/gky1133/5193331">&quot;Open Targets Platform: new developments and updates two years on&quot;</a></p>
                </div>


                <div class="ot-docs-section">

                    <h4><a name="connect"></a>Connect with us</h4>

                    <p>You can follow the team and keep up with the latest news on Open Targets through our social media channels <a href="https://twitter.com/targetvalidate/">Twitter</a>, <a href="https://www.facebook.com/OpenTargets/">Facebook</a> and <a href="https://www.linkedin.com/company/centre-for-therapeutic-target-validation">LinkedIn</a>. If you’ve got questions or feedback, you can also <a href="&#x6D;&#x61;&#x69;&#x6C;&#x74;&#x6F;&#x3A;&#x73;&#x75;&#x70;&#x70;&#x6F;&#x72;&#x74;&#x40;&#x74;&#x61;&#x72;&#x67;&#x65;&#x74;&#x76;&#x61;&#x6C;&#x69;&#x64;&#x61;&#x74;&#x69;&#x6F;&#x6E;&#x2E;&#x6F;&#x72;&#x67;">email us</a>.</p>

                </div>


            </div>
        </div>


    </div>

</div>
